These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32286174)

  • 1. Harnessing Cross-Reactive CD8
    Uddbäck I; Kohlmeier JE; Thomsen AR; Christensen JP
    Viral Immunol; 2020 Apr; 33(3):201-207. PubMed ID: 32286174
    [No Abstract]   [Full Text] [Related]  

  • 2. OVX836 Heptameric Nucleoprotein Vaccine Generates Lung Tissue-Resident Memory CD8+ T-Cells for Cross-Protection Against Influenza.
    Del Campo J; Bouley J; Chevandier M; Rousset C; Haller M; Indalecio A; Guyon-Gellin D; Le Vert A; Hill F; Djebali S; Leverrier Y; Marvel J; Combadière B; Nicolas F
    Front Immunol; 2021; 12():678483. PubMed ID: 34177921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza vaccines: T-cell responses deserve more attention.
    Schotsaert M; Saelens X; Leroux-Roels G
    Expert Rev Vaccines; 2012 Aug; 11(8):949-62. PubMed ID: 23002976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza-induced lung T
    Van Braeckel-Budimir N; Harty JT
    Immunol Cell Biol; 2017 Sep; 95(8):651-655. PubMed ID: 28405016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zymosan by-passes the requirement for pulmonary antigen encounter in lung tissue-resident memory CD8
    Caminschi I; Lahoud MH; Pizzolla A; Wakim LM
    Mucosal Immunol; 2019 Mar; 12(2):403-412. PubMed ID: 30664708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutting edge: rapid boosting of cross-reactive memory CD8 T cells broadens the protective capacity of the Flumist vaccine.
    Slütter B; Pewe LL; Lauer P; Harty JT
    J Immunol; 2013 Apr; 190(8):3854-8. PubMed ID: 23467935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine.
    Schmidt A; Lapuente D
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33525620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.
    Deliyannis G; Kedzierska K; Lau YF; Zeng W; Turner SJ; Jackson DC; Brown LE
    Eur J Immunol; 2006 Mar; 36(3):770-8. PubMed ID: 16435281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza Virus.
    Lee YN; Lee YT; Kim MC; Gewirtz AT; Kang SM
    J Immunol; 2016 Mar; 196(6):2637-45. PubMed ID: 26864033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
    Crank MC; Mascola JR; Graham BS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S107-S109. PubMed ID: 30715413
    [No Abstract]   [Full Text] [Related]  

  • 11. Establishment of functional influenza virus-specific CD8(+) T cell memory pools after intramuscular immunization.
    Wang Z; Chua BY; Ramos JV; Parra SM; Fairmaid E; Brown LE; Jackson DC; Kedzierska K
    Vaccine; 2015 Sep; 33(39):5148-54. PubMed ID: 26277069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine.
    Tchilian E; Holzer B
    Viruses; 2017 May; 9(5):. PubMed ID: 28475122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary antigen encounter regulates the establishment of tissue-resident CD8 memory T cells in the lung airways and parenchyma.
    McMaster SR; Wein AN; Dunbar PR; Hayward SL; Cartwright EK; Denning TL; Kohlmeier JE
    Mucosal Immunol; 2018 Jul; 11(4):1071-1078. PubMed ID: 29453412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic 4-1BB signals are indispensable for the establishment of an influenza-specific tissue-resident memory CD8 T-cell population in the lung.
    Zhou AC; Wagar LE; Wortzman ME; Watts TH
    Mucosal Immunol; 2017 Sep; 10(5):1294-1309. PubMed ID: 28051085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human influenza viruses and CD8(+) T cell responses.
    Grant EJ; Quiñones-Parra SM; Clemens EB; Kedzierska K
    Curr Opin Virol; 2016 Feb; 16():132-142. PubMed ID: 26974887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses.
    Auladell M; Jia X; Hensen L; Chua B; Fox A; Nguyen THO; Doherty PC; Kedzierska K
    Front Immunol; 2019; 10():1400. PubMed ID: 31312199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
    Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
    J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.
    Chua BY; Wong CY; Mifsud EJ; Edenborough KM; Sekiya T; Tan AC; Mercuri F; Rockman S; Chen W; Turner SJ; Doherty PC; Kelso A; Brown LE; Jackson DC
    mBio; 2015 Oct; 6(6):e01024-15. PubMed ID: 26507227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and Maintenance of Conventional and Circulation-Driven Lung-Resident Memory CD8
    Takamura S; Kohlmeier JE
    Front Immunol; 2019; 10():733. PubMed ID: 31024560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.